The Sant Pau Biomedical Research Institute obtains the UNE 166002:2021 certification in recognition of the excellence of its R&D&i management

The Sant Pau Biomedical Research Institute (IIB Sant Pau) has obtained the UNE 166002:2021 certification, granted by AENOR, for its Research, Technological Development and Innovation (R&D&i) management system.

This certification establishes the requirements and practical guidelines for the formulation and development of policies that guarantee the proper management of the entire R&D&i process, systematizing it and integrating it into the rest of the organization’s activities through specific objectives.

It is important to highlight that the accreditation includes all the strategic areas, as well as all the transversal programs of the institute, which represents a recognition of the quality with which it works in all the research groups and other management areas.

Miriam Ors Griera, head of the Innovation and Transfer Unit and deputy director of IIB Sant Pau, says “this certification highlights the great work that is being done in all the R&D activities of the institute. At the same time, it shows the robustness of the integrated quality management system that allows us to maintain the standards defined by our R&D&i policy”.

This certification has been achieved thanks to the joint and coordinated work of the Innovation and Transfer Unit -which forms part of the ITEMAS Platform- and the IIB Sant Pau Quality Unit.

This website uses cookies to improve the browsing experience and perform analytical tasks. If you continue browsing, we understand that you agree our cookies policy. More information